NCT03642171View on ClinicalTrials.gov

Surveillance Study of the Contraceptive Intrauterine Device UT380®

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

July 26, 2018

Primary Completion Date

July 26, 2023

Study Completion Date

September 23, 2024

Conditions
Contraceptive; Complications, Intrauterine
Trial Locations (1)

92100

Quanta Medical, Boulogne-Billancourt

Sponsors

Collaborators (1)

CCD
All Listed Sponsors
collaborator

Prodimed S.A.

OTHER

collaborator

CCD

UNKNOWN

lead

Quanta Medical

INDUSTRY